A Comparison of Four Software Programs for Implementing Decision Analytic Cost-Effectiveness Models

被引:27
|
作者
Hollman, Chase [1 ]
Paulden, Mike [1 ,2 ]
Pechlivanoglou, Petros [3 ,4 ,5 ]
McCabe, Christopher [1 ]
机构
[1] Univ Alberta, Dept Emergency Med, Edmonton Clin Hlth Acad 3 264, 11405 87 Ave NW, Edmonton, AB T6G 1C9, Canada
[2] Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada
[3] Hosp Sick Children, Toronto, ON, Canada
[4] Univ Toronto, Toronto Hlth Econ & Technol Assessment THETA Coll, Toronto, ON, Canada
[5] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada
关键词
EXPECTED VALUE; PERFECT INFORMATION; SAMPLE;
D O I
10.1007/s40273-017-0510-8
中图分类号
F [经济];
学科分类号
02 ;
摘要
The volume and technical complexity of both academic and commercial research using decision analytic modelling has increased rapidly over the last two decades. The range of software programs used for their implementation has also increased, but it remains true that a small number of programs account for the vast majority of cost-effectiveness modelling work. We report a comparison of four software programs: TreeAge Pro, Microsoft Excel, R and MATLAB. Our focus is on software commonly used for building Markov models and decision trees to conduct cohort simulations, given their predominance in the published literature around cost-effectiveness modelling. Our comparison uses three qualitative criteria as proposed by Eddy et al.: "transparency and validation", "learning curve" and "capability". In addition, we introduce the quantitative criterion of processing speed. We also consider the cost of each program to academic users and commercial users. We rank the programs based on each of these criteria. We find that, whilst Microsoft Excel and TreeAge Pro are good programs for educational purposes and for producing the types of analyses typically required by health technology assessment agencies, the efficiency and transparency advantages of programming languages such as MATLAB and R become increasingly valuable when more complex analyses are required.
引用
收藏
页码:817 / 830
页数:14
相关论文
共 50 条
  • [21] A COMPARISON BETWEEN ICER AND NICE COST-EFFECTIVENESS MODELS
    Cockerill, K.
    Ward, K.
    Higgins, A. S.
    Gaebler, J. A.
    VALUE IN HEALTH, 2019, 22 : S251 - S251
  • [22] TEMPORAL UNCERTAINTY AND DECISION- MAKING IN COST-EFFECTIVENESS MODELS
    Alvarez, Sanchez J.
    VALUE IN HEALTH, 2022, 25 (12) : S350 - S350
  • [23] COST-EFFECTIVENESS OF BREAST CANCER SCREENING AND PREVENTION - A SYSTETMATIC REVIEW OF DECISION-ANALYTIC MODELS FOR EUROPEAN SETTINGS
    Muehlberger, N.
    Sroczynski, G.
    Gogollari, A.
    Jahn, B. J. Beate
    Pashayan, N.
    Widschwendter, M.
    Siebert, U.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 365 - 365
  • [24] Confidence intervals for cost-effectiveness ratios: A comparison of four methods
    Polsky, D
    Glick, HA
    Willke, R
    Schulman, K
    HEALTH ECONOMICS, 1997, 6 (03) : 243 - 252
  • [25] COST-EFFECTIVENESS OF BREAST CANCER SCREENING AND PREVENTION - A SYSTETMATIC REVIEW OF DECISION-ANALYTIC MODELS FOR EUROPEAN SETTINGS
    Muehlberger, N.
    Sroczynski, G.
    Gogollari, A.
    Jahn, B. J. Beate
    Pashayan, N.
    Widschwendter, M.
    Siebert, U.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 672 - 672
  • [26] Effectiveness and cost-effectiveness of comprehensive rehabilitation programs
    Uhlig, T
    Finset, A
    Kvien, TK
    CURRENT OPINION IN RHEUMATOLOGY, 2003, 15 (02) : 134 - 140
  • [27] CALIBRATION APPROACH IMPACT ON HEALTH AND COST-EFFECTIVENESS OUTCOMES IN A DECISION ANALYTIC FRAMEWORK
    Morina, D.
    Diaz, M.
    VALUE IN HEALTH, 2017, 20 (09) : A407 - A408
  • [28] COST-EFFECTIVENESS OF TRANSRADIAL PERCUTANEOUS CORONARY INTERVENTION: A DECISION-ANALYTIC MODEL
    Amin, Amit P.
    Marso, Steven P.
    Chhatriwalla, Adnan
    Safley, David
    Kennedy, Kevin
    House, John
    Mills, Rebecca
    Salisbury, Adam
    Spertus, John
    Cohen, David
    Baklanov, Dmitri
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (13) : E338 - E338
  • [29] DECISION AND COST-EFFECTIVENESS ANALYSIS
    MARLEY, DS
    JOURNAL OF FAMILY PRACTICE, 1990, 30 (02): : 233 - &
  • [30] Cost-effectiveness of abciximab after coronary stenting: A decision-analytic model
    Rodriguez, O
    Cutlip, DE
    Kuntz, RE
    Cohen, DJ
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 31 (02) : 51A - 51A